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Background: Racial disparities in blood pressure control are well established; however the impact of low health
literacy (LHL) on blood pressure has garnered less attention. Office based interventions that are created with
iterative patient, practice and community stakeholder input and are rolled out incrementally, may help address
these disparities in hypertension control. This paper describes our study protocol.
Methods/design: Using a community based participatory research (CBPR) approach, we designed and
implemented a cohort study that includes both a practice level and patient level intervention to enhance the care
and support of patients with hypertension in primary care practices in a rural region of eastern North Carolina. The
study is divided into a formative phase and an ongoing 2.5 year implementation phase. Our main care
enhancement activities include the integration of a community health coach, using home blood pressure
monitoring in clinical decision making, standardizing care delivery processes, and working to improve medication
adherence. Main outcomes include overall blood pressure change, the differential change in blood pressure by race
(African American vs. White) and health literacy level (low vs. higher health literacy).
Discussion: Using a community based participatory approach in primary care practice settings has helped to
engage patients and practice staff and providers in the research effort and in making practice changes to support
hypertension care. Practices have engaged at varying levels, but progress has been made in implementing and
iteratively improving upon the interventions to date.
Trial registration: ClinicalTrials.gov NCT01425515.
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Hypertension affects more than 67 million persons in
the US [1] and increases the risk of all-cause mortality,
mortality due to heart disease, stroke, chronic kidney
disease, and heart failure, and morbidity associated with
non-fatal cardiovascular disease [2]. Although treating
and controlling hypertension is the single most effective
clinical service for reducing mortality [3], blood pressure* Correspondence: Jacqueline_halladay@med.unc.edu
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reproduction in any medium, provided the oris currently not controlled in more than half of American
adults with this condition [1].
Compared with Whites, African Americans have a higher
adjusted prevalence of hypertension (40.1% vs. 27.4%) [4],
and are more likely to be aware of and receive treatment
for their disease [4]. But, African Americans continue to
have lower rates of hypertension control compared with
Whites (33.4% vs. 36.8%) [4]. African Americans acquire
the disease at younger ages [5] and have higher rates of
severe hypertension than Whites [5,6]. These factors
contribute to an 80% higher stroke mortality rate, 50%
higher heart disease mortality rate, and a 320% greater
rate of hypertension-related end stage renal disease than
in the general population [7,8].l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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established. However, the impact of low health literacy
(LHL) on blood pressure has garnered less attention
[9,10]. LHL makes it more difficult to understand and
use health information and may be an obstacle to good
BP control. Over 90 million adults lack the literacy
skills needed to effectively function in the health care
environment [11]. LHL is one of a number of key barriers
to following medical and lifestyle hypertension manage-
ment regimens [12,13] including understanding routine
prescription information [14].
To reduce hypertension disparities in hypertension
control by race and literacy, we used a community based
participatory research (CBPR) approach to design and test
an ongoing practice and patient level intervention in a
rural region of eastern North Carolina that lies within the
“stroke belt”. Our overarching goal is to narrow the gap in
blood pressure control between African Americans and
Whites and among those with lower and higher health
literacy by involving six primary care practices and com-
munity partners in a collaborative effort to lower blood
pressure and reduce disparities in blood pressure control.
Our main outcomes are overall blood pressure change
and the differential change in blood pressure by race
(African American vs. White) and health literacy level
(low vs. higher health literacy) among people with
hypertension. The objective of this paper is to describe
our study methods.
Methods/design
Study overview
The study is part of an ongoing Heart Healthy Lenoir
(HHL) study which is a five-year cardiovascular risk (CVD)
reduction project in a geographically defined area in rural
Southeastern US. The HHL study started in June 2010
and will run for 5 years. As depicted in Figure 1, the over-
arching HHL study is a community level project that is
designed to improve lifestyle, environmental factors, and
hypertension control in eastern NC. Six primary care
practices within the region are involved in the practice
level hypertension care quality improvement (QI) interven-
tion study (the Practice Intervention). Within the practicesFigure 1 Heart Healthy Lenoir Study Components.there is an embedded patient level cohort study of patients
with uncontrolled hypertension (the Patient Intervention).
This paper only describes the Practice and Patient Inter-
vention studies which were designed and implemented
simultaneously.
The study is divided into a formative phase that ended
in July 2011 and an ongoing 2.5 year implementation
phase (see Figure 2). During the formative phase, we
interviewed patients, providers, and office staff in order to
gain insights into the existing resources and challenges
that affect hypertension control in their region. This infor-
mation then guided the design of the various Practice and
Patient Intervention components that are currently being
implemented. During the implementation phase, we engage
practices on site in their improvement efforts and via
formal educational opportunities that we deliver at regional
quarterly dinner meetings.
Our Data Safety and Monitoring Board meets every 6
months throughout the project to ensure the safety of the
intervention components and provide advice on study
related issues. The Biomedical Institutional Review Board
at the University of North Carolina reviewed and approved
this project.
Participant recruitment
Identification of practices for the practice intervention
To identify practices to invite into the study, we generated
lists from the local yellow pages, obtained recommenda-
tions from employees at the regional hospital, and received
direct recommendations from a provider in one of the
primary care practices who has participated in projects
with members of our research team in the past.
We initially contacted 8 practices, and 5 agreed to learn
more about the study via a face-to-face visit with the study
investigators. Four ultimately agreed to participate. To
replace the one practice that chose to not participate,
we added another practice from this region that we were
not aware of at the onset of our recruitment efforts.
Thus, 5 primary care practices participated during the
formative phase (June 2010-July 2011) and a 6th practice,
that was established in 2012, joined during the implemen-
tation phase.
Figure 2 Educational and Behavioral Interventions targeting psychosocial and systems factors to empower practice staff, providers
and patients with skills and resources to enhance Blood Pressure (BP) control.
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general study participation, $30 per subject enrolled into
the Patient Intervention cohort study in order to partially
compensate them for their time, and $10 per study-related
venipuncture.
Identifying patients for the patient intervention:
recruitment into the study cohort
We worked with practices in the formative phase to find
the most feasible way to identify patients with uncon-
trolled hypertension to participate in the cohort study.
Due to differences in a practices’ ability to generate lists
of patients with uncontrolled hypertension from their
electronic health records (EHR’s), we helped practices
create unique mechanisms to identify potential subjects
for the study. For practices that could not generate such
lists from their EHR’s, practice staff members documented
the blood pressure of each adult patient on their daily
patient schedules and faxed these lists to our study
personnel weekly. In order to create a cohort of patients
with uncontrolled hypertension, patients with a systolic
BP of 150 mmHg or greater were invited to participate
via a mailed letter that was signed by their primary care
practice leaders. Approximately one week later, each of
these potential participants was called by our study
personnel and received an informational “robo call”. The
robo call messages were audiotaped using the voice of a
practice staff member.
We offered patients a $40 gift card for completing the
enrollment visit and provide $25 gift cards for each of 4follow up visits with the regionally based study team. The
subjects recruited into the Patient Intervention received a
home blood pressure monitor at their enrollment visit and
are provided with a health coach to assist them with their
self-management efforts via counseling provided over
the phone.
Overall inclusion and exclusion criteria for the Patient
Intervention study are listed in Table 1. Patients who
were ineligible based upon the results of their laboratory
values received a call from one of the study investigators to
explain why they could not participate. If deemed ineli-
gible, the subjects kept their blood pressure cuff and initial
incentive payment.Patient intervention: initial enrollment and follow-up
data collection visits
Enrollment visit (completed)
Cohort study subjects that remained eligible after a pre-
screening call met with a research assistant for an initial
1.5-hour enrollment visit. During this visit subjects
completed the baseline questionnaire, provided informed
consent, had laboratory tests and biometrics measure-
ments obtained and were assessed for health literacy using
the Short Test of Functional Health Literacy in Adults
(s-TOFHLA). Subjects were provided with either an
Omron Model BP 785 electronic home blood pressure
monitor (HBPM) with one size cuff or the OMRON
BP-652 wrist cuff if their upper arm circumference was
greater than 17 inches.
Table 1 HHL inclusion and exclusion criteria
Inclusion criteria: Exclusion criteria:
18 years or older Non-English speaking
Able and willing to give informed consent Current treatment for psychosis
A current patient of 1 of the 6 participating practices Advanced dementia
Current substance abuse
Diagnosis of hypertension by primary care physician or have 3
documented blood pressures above 150/90 mmHg
Lack of phone access
History of malignancy, other than non-melanoma
Skin cancer, that has not been in remission or cured surgically for >5 years
Systolic blood pressure≥ 150mmHg at their most recent clinic visit Estimated creatinine clearance≤ 30 ml/min
Physician approval to participate in the study Pregnant
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(ongoing)
The instruments used for all data collection are provided in
Table 2. Follow up visits occur at 6,12, 18 or 24 months
post enrolment. Biometric measures include height, weight,
heart rate, and blood pressure. Our research assistants use
the Omron HEM-907 automated blood pressure monitor
(Omron Healthcare, Inc., Vernon Hills, IL) and record
the average of 3 sequential measurements obtained at
60-second intervals. All blood pressure measurements
are taken in the seated position and after a 5 minute rest
[9,11]. Weight is measured using a Seca model 770
electronic personal scale (SECA Corporation, Hanover,
MD) that has a maximum capacity of 200 kg (440 lb)
and accuracy within 50 grams for weights less than 150
kg and within 100 grams for weight > 150 kg. Height is
measured to the nearest 1/8 inch using a Schorr stadi-
ometer (Schorr Productions, Olney, MD). Serum creatin-
ine, estimated glomerular filtration rate, hemoglobin A1C,
HDL-C, and total cholesterol values are processed by
Labcorp, Burlington, NC.
Study design: choice of a cohort design
In our early discussions with stakeholders representing
the health care workforce in this region, we learned that
practice providers and staff members, the majority of whom
had never participated in research, were most comfortable
with designing the HHL study using a quality improvement
approach and one that would have a limited impact on
patient flow. Because the study targeted practice level
and patient level changes, the risk of contamination of a
control group was high. The community also desired to
avoid withholding the patient level phone-based coaching
component from a control group.
Non-randomized observational trial designs are increas-
ingly used for the evaluation of quality improvement and/
or practice-based interventions where rigorous and high
fidelity interventions are not feasible or desirable [15,16].
Thus we determined that a cohort design best met the
needs of this study.Using a community based participatory approach
We chose to use a CBPR approach to inform the design
and implementation of this study as it offers a useful
method for initial and continued practice engagement in
the research process and allows for targeted adaptation
of the research activities both within and among prac-
tices [17]. During the formative phase of the study, we
interviewed multiple stakeholder groups, including staff
members, providers, and patients from the participating
practices to help design the practice and patient level
intervention. We continue to use CBPR in the phasic roll
out of the Practice Intervention in order to minimize prac-
tice burden, introduce new elements only once practices
have demonstrated confidence in taking on new activities,
and to ensure that the practice staff members and providers
continue to have a voice in designing the ongoing study
related activities.Qualitative data gathering
Formative phase practice interviews
We generated a list of evidenced-based practice interven-
tions that have previously demonstrated a reduction in
blood pressure or an increase in control of blood pressure
in diverse patient populations. Our domains and questions
for the formative phase interview guides drew mainly from
Cochrane reviews and the quality improvement literature
[18,19]. We provided short summaries of potential inter-
vention activities in order to generate ideas regarding the
acceptability and/or feasibility of implementing: 1) team
based care, 2) home blood pressure monitoring protocols,
3) processes to address medication adherence, 4) a patient
intervention coaching program, and 5) the use of standard-
ized care templates.
We conducted the interviews in two groups at each
practice; one with practice leadership (practice manage-
ment, lead nurses, and providers) and the other with
practice staff (front office personnel, billing staff, and
other nursing/clinical staff ) to maximize the diversity of
perspectives and minimize single source bias.
Table 2 Heart healthy lenoir patient and practice level measures*
Variable Instrument Time
Baseline Follow-up
Patient level measures
Blood pressure Average of 3 readings X Xa
Literacy Short-TOFHLA X
Socio-demographic characteristics Patient self-report/survey (Self Report)
Age Self-report X
Gender Self-report X
Marital status Self-report X
Education (grade level) Self-report X
Race/ethnicity (self-report) Self-report X
Household income Self-report X
Employment Self-report X Xf
Relative social position MacArthur Scale X
Health insurance Self-report X Xc
Social support Medical outcomes study/perceived social support X
Biometrics
Height Stadiometer X
Weight SECA scale X Xa
Creatinine/GFR Laboratory test X Xc
Cholesterol Laboratory test X Xc
A1c Laboratory test X Xd
Clinical characteristics
Medical comorbidities: Heart failure/high Cholesterol/Lung
Disease/Chronic Back Pain/ Cancer/Arthritis/Fibromyalgia/
Diabetes/Hypertension/COPD/Obstructive Sleep Apnea/
Renal Insufficiency/Stroke
Self-report X
Depression Mental Health Inventory (MHI-5) X Xe
Smoking status Self-report X Xa
Current medications and supplements List generated X Xa
Patient reported outcomes
Quality of life survey SF-12 X Xa
Medication side-effects that limit use Self-report X Xc
Knowledge/behaviors/beliefs Self-report X Xa
Medication adherence (ADH) Morisky adherence score X Xa
Exercise RESIDE X Xd
Diet Block fruit-vegetable-fiber screener X Xd
Understanding illness HTN beliefs questionnaire X Xc
Participatory decision making (PDM) PDM survey X Xc
Patient activation Short- patient activation measure X Xa
Social determinants of health Social determinants and civic engagement questionnaire Xb
Access to medication Cost-related access to medication survey X Xa
Practice Level QI Process Variables (Selected Visit planner items)
Action taken if BP uncontrolled Visit Planner data Continuous
Consequences of uncontrolled HTN discussed Visit Planner data Continuous
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Table 2 Heart healthy lenoir patient and practice level measures* (Continued)
Assess medication adherence Visit Planner data Continuous
Assess for understanding of instructions Visit Planner data Continuous
Percent patients with HTN with BP’s < 140 mmHg and < 90mmHg Performance reports Monthly and yearly
aVisits with study personnel at 6,12,18 and 24 months post enrollment visit.
bonly measured at 6 month visit.
cmeasured at 12 and 24 months.
dmeasured at 6, 12, 24 months.
emeasured at 12, 18, 24 months.
fmeasured at 12 months.
*All patients are given the option to have the study documents read to them.
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We conducted face-to-face interviews with 8–10 hyperten-
sive patients from each practice. Patients for this activity
were purposely sampled to include a diversity of race,
gender, health literacy and blood pressure control. Locally
hired research staff members conducted the interviews.
Attempts were made to match interviewer/interviewee by
race; this occurred in over 90% of the interviews. The
interviews explored domains of overall health concerns,
general hypertension knowledge and regional barriers to
controlling hypertension. Patients were asked two questions
regarding their experiences with health inequity. The
detailed results of the practice and patient interviewers
are being submitted for publication elsewhere.Conceptual model to enhance blood pressure control
By combining research tested approaches to hypertension
management with our qualitative research in the commu-
nity, we developed a conceptual model of care that we
predict will improve hypertension control and reduce
disparities in the targeted community. The model works
at several levels to change practice and patient behavior.
For the practice level intervention, we adapted the Promot-
ing Action on Research Implementation in Health Services
(PARIHS) model to conceptualize practice change [13,17].
The practices and the community based health coach
are taught communication and behavior change strategies
based on Social Cognitive Theory [20], the Transtheoretical
Model [21] and Motivational Interviewing [22,23]. The
operationalization of these theories into our intervention
activities are described below and the overall schema
based upon the formative year experience is presented
graphically in Figure 2.
Key practice level content areas include developing and
enhancing skills in performing the following activities: 1)
using a medication algorithm to guide selection of anti-
hypertensive medications and other therapeutic recom-
mendations, 2) using team approaches to assist patients
with medication adherence, 3) reviewing techniques to
accurately measure blood pressure, 4) abstracting and
reflecting upon clinical performance data, 5) devising
processes to standardize care delivery including decisionsupport, and 6) incorporating health coaching strategies in
their care delivery.
Key patient level content areas include partnering with a
health coach to enhance knowledge and confidence regard-
ing the use of home blood pressure monitoring, establishing
health goals, learning how to participate in their care
decisions, and improving medication adherence.Practice and patient interventions
Practice intervention component 1: the “design team”
We invited a member from each practice to participate
in our “design team” that meets via conference call every
1–2 months throughout the formative and implementation
phases. During the design team calls, the study team and
the practice representatives address general study issues
and fine-tune study procedures and tools that are then
implemented in the practice settings and discussed with
the larger audience of staff members and providers at
the regional dinner meetings (see below).
For example, to date the design team has provided
suggestions regarding: 1) each of the proposed decision
support items included on the visit planner , 2) components
of the hypertension medication algorithm, 3) methods for
obtaining and sharing the performance data, and 4) content
for the regional dinner meeting educational sessions.Practice intervention component 2: quarterly
dinner meetings
We use a quarterly dinner meeting format to discuss study
related issues and to deliver an educational curriculum
regarding QI in hypertension care. All practice staff and
providers are invited as well as other stakeholders from
the community. The curriculum includes topics such as
reviewing performance data noted below, working as teams
to standardize care delivery, helping patients better adhere
to therapeutic regimens, providing updates on pharma-
cotherapeutic options for hypertension control, reviewing
challenging patient cases, attaining health equity, under-
standing the principles of health literacy, and understanding
and incorporating the role of coaching and motivational
interviewing in patient care. Continuing Medical Education
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events.Practice intervention component 3: practice facilitation
Each investigator is assigned to a practice and acts as a
“facilitator”. The facilitator visits practices every 1–2
months as needed and helps the practices implement study
related activities. Practice facilitators engage practice staff
and providers in the design and use of decision support
and review performance data with them during visits.Practice intervention component 4: measurement
of hypertension control and collaborative partnerships
Given that we knew at the outset that the HHL study
would coincide with other initiatives such as the Office of
the National Coordinator’s (ONC) EHR Incentive program,
we partnered with the region’s Area Health Education
Center (AHEC) in order to minimize practice burden
by aligning our respective data requirements and data
standards. We used the same outcome measure of hyper-
tension control as promulgated by the ONC program and
endorsed by the national quality forum (NQF 0018; see
National Quality Forum - www.qualityforum.org). We in-
vite the AHEC stakeholders to all of our dinner meetings
and work collaboratively with AHEC partners in offering
practice support.
Each practice has a lead IT staff member who is respon-
sible for generating practice level hypertension control data.
These members met as a group in the formative phase with
one of the HHL investigators to discuss strategies on how
to generate this measure from EHR’s and how to examine
this data by race and ethnicity. The practice leadership is
encouraged to review this data on a monthly basis.Practice intervention component 5: medication algorithm
We created a HHL study hypertension treatment algorithm
in the formative phase based on the Seventh Report of
the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood pressure [2]
and the AHA/ASH/PCNA Scientific Statement regarding
the use of home blood pressure monitors [24]. The inves-
tigative team provided the draft algorithm to the Design
Team members during two conference calls where edits
and recommendations were incorporated. The algorithm
accounted for medication costs and specifically included
options that were available at the regional pharmacies’
generic “$4” lists. All practice staff and providers reviewed
the algorithm at a dinner meeting. The final algorithm
document was distributed to the practices and made
available on the study’s website (http://www.hearthealthy-
lenoir.com/practices).Practice intervention component 6: design of visit
planner/decision support
The use of standardized templates for care delivery was
a relatively new concept for the participating practices,
thus we planned our roll out for the visit planner imple-
mentation over time and in three stages to minimize
impact on patient flow. The overall goal is to encourage
the practice staff members and providers to function as a
team to address blood pressure knowledge, goal setting,
and medication adherence with their patients. We also
encourage the providers and staff to document the specific
actions they take to support the patients’ care in cases
where the blood pressure is not well controlled. Providers
and clinical staff members are asked to discuss home
blood pressure measurements with each patient and the
providers are encouraged to take home monitoring data
into account when determining whether or not blood
pressures are controlled and if actions are required.
Practices are asked to use the visit planners with all of
their hypertensive patients one or more days per week.
The forms are collected by the research staff monthly
and the data is used to document practice changes in
practice patterns. We provide this data back to practice
leadership and staff members via in office coaching visits
and at the quarterly dinner meetings. A copy of our Phase
3 visit planner is available at www.hearthealthylenoir.com/
practices.
Patient intervention component 1: home blood
pressure monitoring
Trained research assistants provide instruction on accurate
home blood pressure measurement technique based upon
methods outlined by The Seventh Report of the Joint Na-
tional Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure [2] to subjects in-
cluded in the Patient Intervention. The main instruction
occurred at the baseline enrollment visit, but further
instruction is provided when deemed appropriate at
subsequent study visits or on an ad hoc basis if subjects
require additional assistance. Patient Intervention subjects
are shown how to document their BP’s in a log book and
are instructed to bring the information to each visit with
their healthcare provider or research team and to have
this information available for phone coaching calls. At a
minimum, subjects are asked to record blood pressures
three times a week for 2 weeks before each provider visit
and to obtain some of these upon wakening and some in
the afternoons.
Patient Intervention component 2: phone coaching
curriculum
We partnered with Bosworth and colleagues to adapt their
phone coaching curriculum for the HHL study [25-29].
Slight modifications were made in the original format in
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Microsoft and study tracking database housed at UNC
Chapel Hill. Our coach was formally trained in motiv-
ational interviewing techniques and completed course
work in an Integrative Health Coaching Certification
Program. A second coach was trained by the primary
coach during year 3 to keep up with call demand. Individ-
ual subjects are assigned to one coach.Table 3 Phone coaching schedule and content
Encounter # Module descriptor:
1, 7 Opening a
Medication module a, literacy
Side effects a
Memory b
Closing a
2, 8 Medication module, literacy
Hypertension knowledge b
Decision making b
Side effects, closing
3, 9 Diet c
Weight b
Medication module, literacy, side effects, closing
4, 10 Exercise b
Social & medical barriers
Memory, Medication module, literacy, side effects,
5, 11 Stress b
Alcohol b
Medication module, literacy, side effects, closing
6, 12 Medication module, literacy, side effects, memory,
All Patient initiated
a =Modules activated at every phone call for only those identified as having a prob
b =Modules activated at specific intervals for only those identified as having a prob
c =Modules activated at specific intervals for all individuals.
* Your guide to lowering blood pressure with DASH. National Heart, Lung, and Bloo
pdf. Accessed April 30, 2013.Each coach makes 4 attempts to reach each subject
with the scheduled encounter described in Table 3. The
format for the coaching calls includes a review of home
blood pressure measurements, medications, and issues
that may impact adherence. Each participant and his or
her coach review a variety of lifestyle topics and jointly
develop realistic goals that are reviewed at subsequent calls.
The health coach provides feedback on the participant’sModule activities:
Describe purpose of call, review study
Review blood pressure medication prescribed,
ascertain if taking as prescribed, encourage
individuals to contact providers if change in
medications, include family member/friends in
description of blood pressure medication purpose,
information tailored based upon literacy level and
specific to blood pressure medications patients are
currently taking, suggest questions to ask primary
care provider.
Determine side effects experienced and seriousness
and discuss
Offer mnemonic strategies, explain the importance
of taking blood pressure medication consistently
Encourage patient to take blood pressure between
primary care provider visits
Reviews medication changes
Educate and address applicable risk factors: diabetes,
race, heredity, new diagnosis
Role play to help patient interact with provider more
effectively
Review dietary approaches to stop hypertension*
diets. Discuss sodium and food label reading
Discuss relationship of weight with hypertension and
how to reduce weight
Provide information based upon stage of change
Ascertain social support, determine if patient needs
referrals, help with refills and provide information
about support groups and local resources
closing
Discuss methods for identifying and reducing stress
Provide information on the relationship between
alcohol use and hypertension. Resources are
provided.
closing
Address patient concern at time of patient initiated
call to phone coach.
lem.
lem.
d Institute. http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.
Table 4 Sample size estimates to detect various differences
in mean changes of systolic BP between African Americans
and Whites using a one-sided t-tests with alpha = 0.05 and
standard deviation of change =16 mmHg
Power
(1-Beta)
Sample
size - African
Americans
Sample
size - Whites
Difference in
mean changes of
SBP between two races
0.80027 792 792 2.0
0.80033 507 507 2.5
0.80023 352 352 3.0
0.80125 260 260 3.5
0.80086 199 199 4.0
0.80002 157 157 4.5
0.80193 128 128 5.0
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appropriate. The average call time is approximately 15
minutes. A brief one-page summary of each telephone
encounter is sent to the subject’s health care provider.
Evaluation - outcome assessment
Practice intervention - blood pressure control
We collect practice level data reflecting the percentage of
hypertensive patients seen each month who are controlled,
defined as having a systolic blood pressure less than 140
mmHg and a diastolic blood pressure less than 90 mmHg
at their office visit. Every six months we separately pull
data to reflect a full year of BP’s using the most recent
recorded BP’s to generate the control rates. The monthly
and yearly control data are stratified by race and ethnicity.
This data is shared with the stakeholders at our office
visits, design team meetings and dinner meetings.
Patient intervention – change in blood pressure
Our primary patient level analysis will be based upon
changes in blood pressure among individuals in the Patient
Intervention. We will evaluate the differential effect of the
intervention by race (African American and White) and
health literacy level (low versus higher health literacy) on
blood pressure.
Other patient intervention outcomes measures
In addition to the biometric measures, we assess several
social, demographic, and patient reported outcome vari-
ables, as outlined in Table 2, that can be analyzed as
secondary outcomes.
Sample size and power calculation: patient intervention
Our primary analyses will be to evaluate the effect of the
Patient Intervention on reducing blood pressure and to
compare the change in mean systolic blood pressure
among African Americans and Whites to test our primary
hypothesis that African American patients will have greater
improvement in mean systolic blood pressure at the end of
1 year of engaging in the intervention. Based on a previous
study [12], we estimated that the within-practice intraclass
correlation for change in systolic BP was zero and standard
deviation was 16 mmHg. We assumed that the baseline
difference in systolic blood pressure between African
Americans and Whites would be approximately 5 mmHg.
We expect the patient intervention to be effective in redu-
cing systolic blood pressure in both groups, but produce a
greater reduction in African Americans by approximately
3.5 mmHg. Table 4 illustrates sample sizes required to
detect various differences in mean systolic blood pressure
reductions between the two races using one-sided tests of
significance at alpha =0.05. With data from 520 subjects,
we will have 80% power to detect a difference of 3.5
mmHg in systolic blood pressure reduction between thetwo races (see in Table 4). Since we expect an attrition rate
of approximately 15%, we planned to enroll 600 hyperten-
sive patients (approximately 300 African Americans and
300 Whites). We will have similar power to detect differ-
ences in mean systolic blood pressure change between high
and low literacy groups, assuming an equal distribution of
literacy.
Discussion
We designed the HHL study using an emerging method-
ology that combines the principles of practice based
research and community based participatory research, the
combination of which is felt to hold great promise for
moving the bar towards achieving health equity [30] and
enhancing awareness regarding issues faced by that
marginalized communities [10]. The study design will
allow us to evaluate the effect of combined practice level
and individual level interventions on blood pressure
control and to assess for differential impact of such a
program by race and literacy levels. CBPR informed
interventions have been successful in reducing other
cardiovascular risk factors [3,31] and are increasingly
focusing on hypertension as a main outcome [4,32].
Notably, in one such CBPR trial that used an analogous
multi-level intervention, trends were noted in improved
blood pressure among the subjects with uncontrolled
hypertension [32]. The findings of our study will comple-
ment this important work, and contribute to our under-
standing of the effectives of CBPR-based interventions in
lowering blood pressure.
Our process has been to adapt evidence-based approaches
to the local context using the resources available. We have
already seen immediate impact and dissemination through
our relationship with the region’s Medicaid Network
organization. They have adapted the phone coaching cur-
riculum to support a new program that helps patients cre-
ate personal health plans, a key self-management resource
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of the practices’ efforts to become patient centered med-
ical homes. By building numerous partnerships, we are
confident that many significant resources will remain in
this community long after the HHL study ends. These
relationships have also built the foundation for further
health services innovations in this region.
Although we are still in the data collection and imple-
mentation phase of the study, we can share several obser-
vations of this work to date. First, the local community
is genuinely interested in the research process and has
contributed to the development of the interventions.
The practices helped us recruit patients for and also
participated in qualitative interviews to allow the research
team to better understand the needs and resources of
the primary care environment. They continue to give
guidance in the design team calls and this feedback
drives the evolution of the Practice Intervention and the
process of linking the work of the community coach to
the practice team.
Second, we have had variable levels of engagement in
the practices to date. When we initially solicited the
participation of local primary care providers, only half
of the practices agreed to join the project. Among the
6 practices currently in the project, engagement is high
among 2, moderate among 2, and low among 2. We are
still in the implementation phase and are taking steps to
increase engagement and to be responsive to the unique
challenges faced by each individual practice. Enhancing
primary care in a resource-limited rural community pre-
sents challenges with setting up an innovative network of
practices that are not geographically close and establishing
ties that facilitate rapid dissemination and implementation
of the interventions. Third, there has been a high turnover
rate in some practices. In two practices, none of the original
physicians, physician assistant and nurse practitioners
remain. This level of turnover presents important limi-
tations to diffusion of information within the practice,
particularly in this setting where provider leadership is
critical to success.
Fourth, although all of the practices in this community
have EHR’s, using the EHR to drive improvements in
care delivery and measurement of care outcomes has
not been straightforward. None of the practices were
able to pull accurate population health data from their
EHR at the onset of the study. With substantial effort
from our study team and the AHEC’s Regional Extension
Center, 4 out of 6 practices can now produce this data.
The challenge of adequate implementation and use of
EHRs to realize any specific benefits to care deliver should
not be underestimated.
We look forward to analysis of study data and exploration
of findings with the community. We anticipate end of data
collection in late 2014 and analyses in early 2015.Abbreviations
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